donderdag 15 maart 2012 - Partnership for Entrepreneurship Education Call - 28/G/ENT/CIP/12/E/N01C01 Lot2

Oproep Financiering: CIP - Entrepreneurship Education

Creating an online platform for European teachers/educators to enable the cross-border exchange of good practice, methods and teaching materials in the field of entrepreneurship education, to help the introduction entrepreneurship as a key competence in school curricula and by this way improve a entrepreneurial mindsets among young people in primary, secondary and tertiary education. This platform allows ongoing support, sources of information, peer advice, successful examples, and didactic materials, which will establish a resource centre close to practitioners, with easy-to-find tools, methods and good practice examples. Goals: - Share learning material, networking and peer learning in this area - Enable networking between developers of entrepreneurship education - Create online community of practitioners - Support educators in the development of pedagogies, concepts and curricula for entrepreneurship education. - Disseminate ideas and methods. - Virtual space – Discussion, Coaching and Work between peers on specifics themes. - Self-assessment of concepts and methods for teaching entrepreneurship or Assessment for peers - Self-sustainability after the end of EU funding. As we intend to contribute to the consortium: AIP-CCI wants to be a partner in a transnational consortium to develop some activities according with the experience of previous projects and to contributing with cross-border collaboration. With our experience we can contribute by collecting and systematizing the existing best practices; promoting the platform to expand de network in Iberian Peninsula; introducing material in the platform; conducting outreach events with the approval of the Ministry of Education and teacher unions. Who We Are: The Portuguese Industrial Association (AIP-CCI) is a national institution that represents the Portuguese companies and was founded in 1837. It is a key player in the Portuguese economy with an important role as advisor to national authorities and the government. During its activity AIP-CCI created 12 associations distributed over different regions of the country. Relevant Activities to the proposal Partnership: • e-learning Training for Teachers • Local support for entrepreneurship through regional associations with infrastructure and resources • Conduct creativity workshops to build and accelerate entrepreneur ideas • Co-work space in Lisbon - the largest center for entrepreneurs cooperation at the national level (120 coworkers are expected) • Animation of a micro training platform with information, forums, virtual support and consultancy; space for exchanges between entrepreneurs. • Animation of a Cooperation platform • Creative Learning& Business Innovation cenference (biannually since 2008) – around 2000 attendees • Creation and Animation of “Plataforma do Empreendedor” (http://www.empreender.aip.pt), that was considered a example of good practice and case studie. • Leonardo Da Vinci 2009-2012: NetKnowing 2.0 • Marketplace - Study of the Impact of ICT in Informal Learning for SMEs Our Intervention Domains: Innovation; Technological Development, Entrepreneurship; Business Cooperation; Training and Consulting, Financing and Internationalization. Our General Activities: Studies, Projects targeted for young adults and SMEs; Training and technical assistance; Development of technical information; Specialized Forums and Seminars; International Missions. Our People Skills and Experience: • Dialogue and Advice to National Authorities; • Project Management: Direction, design, control, operational and financial management; internal and external audit; • Management of projects European and National funded. • Dealing directly with the entrepreneurs, academics, managers and technicians of public and private entities; • Mobilization of business networks; • Divulgation and Advertising of Public Projects

donderdag 15 maart 2012 - Partnership for Entrepreneurship Education Call - 28/G/ENT/CIP/12/E/N01C01 Lot1

Oproep Financiering: CIP - Entrepreneurship Education

Implementation of some training initiatives for the European teacher, to introduce entrepreneurship as a key competence in school curricula and by this way improve a entrepreneurial mindsets among young people in primary, secondary and tertiary education. 1st Goal - Support the development of teachers’ skills and methods in applying entrepreneurial learning to different teaching subjects and to different contexts. • Development of tools and methods (or adaptation/improvement of successful existing ones), based on the definition of desired learning outcomes and including ways of assessing the achievement of those outcomes; • Testing the tools on a small scale, for possible fine-tuning and improvements; • Training school teachers across Europe in how to use the tools and methods developed; • Disseminating the pedagogical methods and materials produced (handbook; pedagogical tools, teaching materials and contents on a website). 2nd Goal - Developing, organising and executing cross-European training/education workshops for teachers of entrepreneurship at institutions of higher education • Cross-country training. • Exchange of experience and teaching methods between 180 higher education educators. As we intend to contribute to the consortium: AIP-CCI wants search partner in a transnational consortium to develop activities according with the experience of previous projects and to contributing with cross-border collaboration to gathering information on best practices Portuguese; testing the tools in some Portuguese schools; organize training and workshop sessions in Lisbon; dissemination of the pedagogical methods and materials produced in the Iberian Peninsula; involve the best business schools, inter-disciplinary universities and technical institutions in Portugal. Who We Are: The Portuguese Industrial Association (AIP-CCI) is a national institution that represents the Portuguese companies and was founded in 1837. It is a key player in the Portuguese economy with an important role as advisor to national authorities and the government. During its activity AIP-CCI created 12 associations distributed over different regions of the country. Relevant Activities to the proposal Partnership: • e-learning Training for Teachers • Local support for entrepreneurship through regional associations with infrastructure and resources • Conduct creativity workshops to build and accelerate entrepreneur ideas • Co-work space in Lisbon - the largest center for entrepreneurs cooperation at the national level (120 coworkers are expected) • Animation of a micro training platform with information, forums, virtual support and consultancy; space for exchanges between entrepreneurs. • Animation of a Cooperation platform • Creative Learning&business Innovation Conference (biannually since 2008) - around 2000 attendees • Creation and Animation of “Plataforma do Empreendedor” (http://www.empreender.aip.pt), that was considered a example of good practice and a case studie. • Leonardo Da Vinci 2009-2012: NetKnowing 2.0 • Marketplace - Study of the Impact of ICT in Informal Learning for SMEs Our Intervention Domains: Innovation; Technological Development, Entrepreneurship; Business Cooperation; Training and Consulting, Financing and Internationalization. Our General Activities: Studies, Projects targeted for young adults and SMEs; Training and technical assistance; Development of technical information; Specialized Forums and Seminars; International Missions. Our People Skills and Experience: • Dialogue and Advice to National Authorities; • Project Management: coordination, design, control, operational and financial management; internal and external audit; • Management of projects European and National funded. • Dealing directly with the entrepreneurs, academics, managers and technicians of public and private entities; • Mobilization of business networks; • Divulgation and Advertising of Public Projects

vrijdag 17 februari 2012 - Streptococcus ..........=Vaccine STREPTOVAK-1

Oproep Financiering: PCRD7 - Coopération - ICT - Call 9

Hello! I'm the author of toxoid vaccine "STREPTOEVAK" designed for animal and bird prophylactics against streptococcal infection and its complications. This biological product is used to treat sick animals as well as infection prevention. This vaccine is unique; there is no analogue of this vaccine in the world. The directions of the use of toxoid vaccine "STREPTOEVAK" were approved on 05.03.2004 by the Chief Veterinary Department. The vaccine has been used successfully in a number of animal breeding farms across Russia. The composition of the biological product is Streptococcus zoepidemicus, inactivated with formalin and deposited on aluminum hydroxide. All males and females are vaccinated 20-30 days before mating in order to treat the latent form of the disease as well as provision of prophylactics of spontaneous abortion, resorption of foetuses, premature labor, mastitis, endometritis and umbilical sepsis. Cows and mares are vaccinated 10-15 days before giving birth. Young animals are vaccinated 10 -15 days prior to the end of weaning as a way of prophylactics of arthritis, glomerulonephritis, psoriasis, and cancer.The main idea, make a similar toxoid vaccine (strep. A,B) for treat and profhilactic for humans against streptococcic and complications:abortion,stillborn,disablement of new-born,sepsis,pneumonia,mastitis,menigites,rheumatism, rheumatic fever, glomerulonephritis, psoriasis and cancer Sincerely yours, Viktor. www.saberespoder.sitecity.ru http://picasaweb.google.com/suegra111/CCTREPTOKOKKOZYAndComplications# -http://www.mdanderson.org/education-and-research/resources-for-professionals/clinical-tools-and-resources/cimer/therapies/nonplant-biologic-organic-pharmacologic-therapies/coley-toxins-scientific.html

donderdag 9 februari 2012 - Streptococcus ..........=Vaccine STREPTOVAK-1

Oproep Financiering: SAFER INTERNET (E-SAFE) - Call 2012

Hello! I'm the author of toxoid vaccine "STREPTOEVAK" designed for animal and bird prophylactics against streptococcal infection and its complications. This biological product is used to treat sick animals as well as infection prevention. This vaccine is unique; there is no analogue of this vaccine in the world. The directions of the use of toxoid vaccine "STREPTOEVAK" were approved on 05.03.2004 by the Chief Veterinary Department. The vaccine has been used successfully in a number of animal breeding farms across Russia. The composition of the biological product is Streptococcus zoepidemicus. All males and females are vaccinated 20-30 days before mating in order to treat the latent form of the disease as well as provision of prophylactics of spontaneous abortion, resorption of foetuses, premature labor, mastitis, endometritis and umbilical sepsis. Cows and mares are vaccinated 10-15 days before giving birth. Young animals are vaccinated 10 -15 days prior to the end of weaning as a way of prophylactics of arthritis, glomerulonephritis, psoriasis, and cancer.The main idea, make a similar toxoid vaccine (strep. A,B) for treat and profhilactic for humans against streptococcic and complications:abortion,stillborn,disablement of new-born,sepsis,pneumonia,mastitis,menigites,rheumatism, rheumatic fever, glomerulonephritis, psoriasis and cancer Sincerely yours, Viktor. www.saberespoder.sitecity.ru http://picasaweb.google.com/suegra111/CCTREPTOKOKKOZYAndComplications# -http://www.mdanderson.org/education-and-research/resources-for-professionals/clinical-tools-and-resources/cimer/therapies/nonplant-biologic-organic-pharmacologic-therapies/coley-toxins-scientific.html

donderdag 9 februari 2012 - Streptococcus ..........=Vaccine STREPTOVAK-1

Oproep Financiering: SAFER INTERNET (E-SAFE) - Call 2012

Hello! I'm the author of toxoid vaccine "STREPTOEVAK" designed for animal and bird prophylactics against streptococcal infection and its complications. This biological product is used to treat sick animals as well as infection prevention. This vaccine is unique; there is no analogue of this vaccine in the world. The directions of the use of toxoid vaccine "STREPTOEVAK" were approved on 05.03.2004 by the Chief Veterinary Department. The vaccine has been used successfully in a number of animal breeding farms across Russia. The composition of the biological product is Streptococcus zoepidemicus. All males and females are vaccinated 20-30 days before mating in order to treat the latent form of the disease as well as provision of prophylactics of spontaneous abortion, resorption of foetuses, premature labor, mastitis, endometritis and umbilical sepsis. Cows and mares are vaccinated 10-15 days before giving birth. Young animals are vaccinated 10 -15 days prior to the end of weaning as a way of prophylactics of arthritis, glomerulonephritis, psoriasis, and cancer.The main idea, make a similar toxoid vaccine (strep. A,B) for treat and profhilactic for humans against streptococcic and complications:abortion,stillborn,disablement of new-born,sepsis,pneumonia,mastitis,menigites,rheumatism, rheumatic fever, glomerulonephritis, psoriasis and cancer Sincerely yours, Viktor. www.saberespoder.sitecity.ru http://picasaweb.google.com/suegra111/CCTREPTOKOKKOZYAndComplications# -http://www.mdanderson.org/education-and-research/resources-for-professionals/clinical-tools-and-resources/cimer/therapies/nonplant-biologic-organic-pharmacologic-therapies/coley-toxins-scientific.html

donderdag 9 februari 2012 - Streptococcus ..........=Vaccine STREPTOVAK-1

Oproep Financiering: CIP - ICT-PSP - Instrument: Pilot Type A

Hello! I'm the author of toxoid vaccine "STREPTOEVAK" designed for animal and bird prophylactics against streptococcal infection and its complications. This biological product is used to treat sick animals as well as infection prevention. This vaccine is unique; there is no analogue of this vaccine in the world. The directions of the use of toxoid vaccine "STREPTOEVAK" were approved on 05.03.2004 by the Chief Veterinary Department. The vaccine has been used successfully in a number of animal breeding farms across Russia. The composition of the biological product is Streptococcus zoepidemicus. All males and females are vaccinated 20-30 days before mating in order to treat the latent form of the disease as well as provision of prophylactics of spontaneous abortion, resorption of foetuses, premature labor, mastitis, endometritis and umbilical sepsis. Cows and mares are vaccinated 10-15 days before giving birth. Young animals are vaccinated 10 -15 days prior to the end of weaning as a way of prophylactics of arthritis, glomerulonephritis, psoriasis, and cancer.The main idea, make a similar toxoid vaccine (strep. A,B) for treat and profhilactic for humans against streptococcic and complications:abortion,stillborn,disablement of new-born,sepsis,pneumonia,mastitis,menigites,rheumatism, rheumatic fever, glomerulonephritis, psoriasis and cancer Sincerely yours, Viktor. www.saberespoder.sitecity.ru http://picasaweb.google.com/suegra111/CCTREPTOKOKKOZYAndComplications# -http://www.mdanderson.org/education-and-research/resources-for-professionals/clinical-tools-and-resources/cimer/therapies/nonplant-biologic-organic-pharmacologic-therapies/coley-toxins-scientific.html

donderdag 9 februari 2012 - Streptococcus ..........=Vaccine STREPTOVAK-1

Oproep Financiering: CIP - ICT-PSP - Instrument: Pilot Type A

Hello! I'm the author of toxoid vaccine "STREPTOEVAK" designed for animal and bird prophylactics against streptococcal infection and its complications. This biological product is used to treat sick animals as well as infection prevention. This vaccine is unique; there is no analogue of this vaccine in the world. The directions of the use of toxoid vaccine "STREPTOEVAK" were approved on 05.03.2004 by the Chief Veterinary Department. The vaccine has been used successfully in a number of animal breeding farms across Russia. The composition of the biological product is Streptococcus zoepidemicus. All males and females are vaccinated 20-30 days before mating in order to treat the latent form of the disease as well as provision of prophylactics of spontaneous abortion, resorption of foetuses, premature labor, mastitis, endometritis and umbilical sepsis. Cows and mares are vaccinated 10-15 days before giving birth. Young animals are vaccinated 10 -15 days prior to the end of weaning as a way of prophylactics of arthritis, glomerulonephritis, psoriasis, and cancer.The main idea, make a similar toxoid vaccine (strep. A,B) for treat and profhilactic for humans against streptococcic and complications:abortion,stillborn,disablement of new-born,sepsis,pneumonia,mastitis,menigites,rheumatism, rheumatic fever, glomerulonephritis, psoriasis and cancer Sincerely yours, Viktor. www.saberespoder.sitecity.ru http://picasaweb.google.com/suegra111/CCTREPTOKOKKOZYAndComplications# -http://www.mdanderson.org/education-and-research/resources-for-professionals/clinical-tools-and-resources/cimer/therapies/nonplant-biologic-organic-pharmacologic-therapies/coley-toxins-scientific.html

donderdag 9 februari 2012 - Streptococcus ..........=Vaccine STREPTOVAK-1

Oproep Financiering: CIP - ICT-PSP - Instrument: Pilot Type B (PB)

Hello! I'm the author of toxoid vaccine "STREPTOEVAK" designed for animal and bird prophylactics against streptococcal infection and its complications. This biological product is used to treat sick animals as well as infection prevention. This vaccine is unique; there is no analogue of this vaccine in the world. The directions of the use of toxoid vaccine "STREPTOEVAK" were approved on 05.03.2004 by the Chief Veterinary Department. The vaccine has been used successfully in a number of animal breeding farms across Russia. The composition of the biological product is Streptococcus zoepidemicus. All males and females are vaccinated 20-30 days before mating in order to treat the latent form of the disease as well as provision of prophylactics of spontaneous abortion, resorption of foetuses, premature labor, mastitis, endometritis and umbilical sepsis. Cows and mares are vaccinated 10-15 days before giving birth. Young animals are vaccinated 10 -15 days prior to the end of weaning as a way of prophylactics of arthritis, glomerulonephritis, psoriasis, and cancer.The main idea, make a similar toxoid vaccine (strep. A,B) for treat and profhilactic for humans against streptococcic and complications:abortion,stillborn,disablement of new-born,sepsis,pneumonia,mastitis,menigites,rheumatism, rheumatic fever, glomerulonephritis, psoriasis and cancer Sincerely yours, Viktor. www.saberespoder.sitecity.ru http://picasaweb.google.com/suegra111/CCTREPTOKOKKOZYAndComplications# -http://www.mdanderson.org/education-and-research/resources-for-professionals/clinical-tools-and-resources/cimer/therapies/nonplant-biologic-organic-pharmacologic-therapies/coley-toxins-scientific.html

donderdag 9 februari 2012 - Streptococcus ..........=Vaccine STREPTOVAK-1

Oproep Financiering: CIP - ICT-PSP - Instrument: Pilot Type B (PB)

Hello! I'm the author of toxoid vaccine "STREPTOEVAK" designed for animal and bird prophylactics against streptococcal infection and its complications. This biological product is used to treat sick animals as well as infection prevention. This vaccine is unique; there is no analogue of this vaccine in the world. The directions of the use of toxoid vaccine "STREPTOEVAK" were approved on 05.03.2004 by the Chief Veterinary Department. The vaccine has been used successfully in a number of animal breeding farms across Russia. The composition of the biological product is Streptococcus zoepidemicus. All males and females are vaccinated 20-30 days before mating in order to treat the latent form of the disease as well as provision of prophylactics of spontaneous abortion, resorption of foetuses, premature labor, mastitis, endometritis and umbilical sepsis. Cows and mares are vaccinated 10-15 days before giving birth. Young animals are vaccinated 10 -15 days prior to the end of weaning as a way of prophylactics of arthritis, glomerulonephritis, psoriasis, and cancer.The main idea, make a similar toxoid vaccine (strep. A,B) for treat and profhilactic for humans against streptococcic and complications:abortion,stillborn,disablement of new-born,sepsis,pneumonia,mastitis,menigites,rheumatism, rheumatic fever, glomerulonephritis, psoriasis and cancer Sincerely yours, Viktor. www.saberespoder.sitecity.ru http://picasaweb.google.com/suegra111/CCTREPTOKOKKOZYAndComplications# -http://www.mdanderson.org/education-and-research/resources-for-professionals/clinical-tools-and-resources/cimer/therapies/nonplant-biologic-organic-pharmacologic-therapies/coley-toxins-scientific.html